Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan

Headache

Volumn 38, Issue 3, 1998, Pages 184-190

  Pfaffenrath, V ^a,e   Cunin, G ^b   Sjonell, G ^c   Prendergast, S ^d  

^a Neurolog Praxis   (Germany)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Kvartersakuten Matteus   (Sweden)

^d GLAXOSMITHKLINE   (United Kingdom)

^e NONE   (Germany)

Author keywords

Double blind; Efficacy; Placebo; Safety; Sumatriptan

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; NAUSEA; ORAL DRUG ADMINISTRATION; PHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TABLET; TREATMENT OUTCOME; VOMITING;

EID: 0031898120     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3803184.x     Document Type: Article

References (14)

1. Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology. 1995;45(suppl 7):S10-S14.
2. Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology. 1995; 45(suppl 7):S5-S9.
3. The Oral Sumatriptan Dose-Defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol. 1991;31:300-305.
4. The Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol. 1991;31:306-313.
5. Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994;241:138-144.
6. Ferrari MD, James MH, Bates D, et al. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia. 1994;14:330-338.
7. Goadsby PJ, Zagami AS, Donnan GA, et al. Oral sumatriptan in acute migraine. Lancet. 1991;338:782-783.
8. Dahlof CG. How does sumatriptan perform in clinical practice? Cephalalgia. 1995;15(suppl 15):21-28.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
10. Rederich G, Rapoport A, Cutler N, Hazelrigg R, Jamerson B. Oral sumatriptan for the long-term treatment of migraine: clinical findings. Neurology. 1995;45(suppl 7):S15-S20.
11. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol. 1991;31:314-322.
12. The Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992;32: 177-184.
13. Geraud GE. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine. Eur Neurol. 1996;36(suppl 2):24-27.
14. Cady RK, Rubino J, Crummett D, Littlejohn TW III. Oral sumatriptan in the treatment of recurrent headache. Arch Fam Med. 1994;3:766-772.